1. Genomic landscape of colorectal carcinogenesis

   • Jin Cheon Kim
   • Walter F. Bodmer

   Review – Cancer Research 20 January 2022 Pages: 533 - 545

   

2. Regulatory effects of lncRNAs and miRNAs on the crosstalk between autophagy and EMT in cancer: a new era for cancer treatment

   • Lihui Si
   • Zecheng Yang
   • Duoduo Zhang

   Review – Cancer Research 27 January 2022 Pages: 547 - 564

   

3. NRAS expression is associated with prognosis and tumor immune microenvironment in lung adenocarcinoma

   • Yueren Yan
   • Zhendong Gao
   • Haiquan Chen

   Original Article – Cancer Research 08 November 2021 Pages: 565 - 575

   

4. Horizontal tumor extent (HZTE) has limited prognostic significance in 2018 FIGO stage I endocervical adenocarcinoma (ECA): a retrospective study of 416 cases

   • Simona Stolnicu
   • Lien Hoang
   • Kay J. Park

   Original Article – Cancer Research 12 November 2021 Pages: 577 - 586

   

5. Vasculogenic mimicry correlates to presenting symptoms and mortality in uveal melanoma

   • Shiva Sabazade
   • Viktor Gill
   • Gustav Stålhammar

   Original Article – Cancer Research Open access 13 November 2021 Pages: 587 - 597

   

6. Expressions and significances of CTSL, the target of COVID‐19 on GBM

   • Qiang Dong
   • Qiao Li
   • Yawen Pan

   Original Article – Cancer Research 22 November 2021 Pages: 599 - 608

   

7. Overexpression of melanoma-associated antigen A2 has a clinical significance in embryonal carcinoma and is associated with tumor progression

   • Leili Saeednejad Zanjani
   • Mahdieh Razmi
   • Monireh Mohsenzadegan

   Original Article – Cancer Research 27 November 2021 Pages: 609 - 631

   

8. Targeting abundant survivin expression in liposarcoma: subtype dependent therapy responses to YM155 treatment

   • Christian Vay
   • Philipp M. Schlünder
   • Andreas Krieg

   Original Article – Cancer Research Open access 03 December 2021 Pages: 633 - 645

   

9. Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients

   • Mette-Triin Purde
   • Rebekka Niederer
   • Lukas Flatz

   Original Article – Cancer Research Open access 07 December 2021 Pages: 647 - 656

   

10. Solitary colorectal liver metastasis: overview of treatment strategies and role of prognostic factors

    • S. Acciuffi
    • F. Meyer
    • A. Altendorf-Hofmann

    Review – Clinical Oncology Open access 16 December 2021 Pages: 657 - 665

11. Treatment and follow-up of rare testis tumours

    • Christian Daniel Fankhauser
    • Josias Bastian Grogg
    • Noel William Clarke

    Review – Clinical Oncology 20 January 2022 Pages: 667 - 671

    

12. A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX)

    • Yuan Cheng
    • Shu-kui Qin
    • Yan-ping Zhu

    Original Article – Clinical Oncology 17 April 2021 Pages: 673 - 684

    

13. Application of circulating genetically abnormal cells in the diagnosis of early-stage lung cancer

    • Xiaochang Qiu
    • Haoran Zhang
    • Dianjie Lin

    Original Article – Clinical Oncology 24 April 2021 Pages: 685 - 695

    

14. Hormonal tumor mapping for liver metastases of gastroenteropancreatic neuroendocrine neoplasms: a novel therapeutic strategy

    • Aya Maekawa
    • Atsushi Kudo
    • Minoru Tanabe

    Original Article – Clinical Oncology 27 April 2021 Pages: 697 - 706

    

15. Real-life drug–drug and herb–drug interactions in outpatients taking oral anticancer drugs: comparison with databases

    • H. Prely
    • C. Herledan
    • C. Rioufol

    Original Article – Clinical Oncology 29 April 2021 Pages: 707 - 718

16. Trastuzumab treatment of patients with early, HER2-positive breast cancer in 17 certified German breast cancer centers

    • Nora Tabea Sibert
    • Simone Wesselmann
    • Olaf Ortmann

    Original Article – Clinical Oncology 29 April 2021 Pages: 719 - 726

    

17. Biopsy-detected Gleason grade 5 tumor is an additional prognostic factor in metastatic hormone-sensitive prostate cancer

    • Bumjin Lim
    • Wonchul Lee
    • Choung-Soo Kim

    Original Article – Clinical Oncology 04 May 2021 Pages: 727 - 734

    

18. Analysis of end-of-life treatment and physician perceptions at a university hospital in Germany

    • Nicole Heerde
    • Wolf-Karsten Hofmann
    • Deniz Gencer

    Original Article – Clinical Oncology Open access 05 May 2021 Pages: 735 - 742

    

19. Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report

    • Ruth-Miriam Koerber
    • Stefanie A. E. Held
    • Annkristin Heine

    Letter to the Editor Open access 16 September 2021 Pages: 743 - 748

    

20. Correction to: MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1

    • Xin-Long Ma
    • Feng Shang
    • Yu-Qi Zhang

    Correction 19 November 2021 Pages: 749 - 750

    

21. Correction to: Inactivation of ICAM1 inhibits metastasis and improves the prognosis of Ewing’s sarcoma

    • Bin Pan
    • Xiangbo Bu
    • Kaijin Guo

    Correction 06 January 2022 Pages: 751 - 751